BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

429 related articles for article (PubMed ID: 24495653)

  • 1. No more metallic cages: an attractive hybrid strategy with bioresorbable vascular scaffold and drug-eluting balloon for diffuse or tandem lesions in the same vessel.
    Naganuma T; Latib A; Ielasi A; Panoulas VF; Sato K; Miyazaki T; Colombo A
    Int J Cardiol; 2014 Apr; 172(3):618-9. PubMed ID: 24495653
    [No Abstract]   [Full Text] [Related]  

  • 2. Computed tomography angiography for guiding and follow-up of magnesium-bioresorbable scaffold implantation.
    Opolski MP; Kepka C; Wojakowski W; Witkowski A
    Clin Res Cardiol; 2019 Mar; 108(3):344-346. PubMed ID: 30182164
    [No Abstract]   [Full Text] [Related]  

  • 3. Arterial Remodeling After Bioresorbable Scaffolds and Metallic Stents.
    Serruys PW; Katagiri Y; Sotomi Y; Zeng Y; Chevalier B; van der Schaaf RJ; Baumbach A; Smits P; van Mieghem NM; Bartorelli A; Barragan P; Gershlick A; Kornowski R; Macaya C; Ormiston J; Hill J; Lang IM; Egred M; Fajadet J; Lesiak M; Windecker S; Byrne RA; Räber L; van Geuns RJ; Mintz GS; Onuma Y
    J Am Coll Cardiol; 2017 Jul; 70(1):60-74. PubMed ID: 28662808
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expansion in calcific lesions and overall clinical outcomes following bioresorbable scaffold implantation optimized with intravascular ultrasound.
    Kawamoto H; Ruparelia N; Latib A; Miyazaki T; Sato K; Tanaka A; Naganuma T; Sticchi A; Chieffo A; Carlino M; Montorfano M; Colombo A
    Catheter Cardiovasc Interv; 2017 Apr; 89(5):789-797. PubMed ID: 27545845
    [TBL] [Abstract][Full Text] [Related]  

  • 5. "Golden tube" with favorable vessel remodeling at four-year follow-up after bioresorbable vascular scaffold implantation for moderate to severe calcified lesions: Insights from intravascular imaging.
    Mitomo S; Candilio L; Tanaka A; Latib A; Colombo A
    Cardiol J; 2018; 25(4):532-533. PubMed ID: 30211931
    [No Abstract]   [Full Text] [Related]  

  • 6. Feasibility and efficacy of bioresorbable vascular scaffolds use for the treatment of in-stent restenosis and a bifurcation lesion in a heavily calcified diffusely diseased vessel.
    Naganuma T; Costopoulos C; Latib A; Sato K; Miyazaki T; Colombo A
    JACC Cardiovasc Interv; 2014 May; 7(5):e45-6. PubMed ID: 24746654
    [No Abstract]   [Full Text] [Related]  

  • 7. Dislodgement of a magnesium bioresorbable scaffold from the delivery system in the left main: A true "nightmaris".
    Cortés C; Jaguszewski M; Schincariol M; Durán-Cortés MA; Limon U; Gutiérrez-Chico JL
    Cardiol J; 2017; 24(6):700-701. PubMed ID: 29297580
    [No Abstract]   [Full Text] [Related]  

  • 8. Follow-up evaluation of unapposed bioresorbable vascular scaffold at a coronary bifurcation using optical coherence tomography.
    Danson E; Bhindi R; Hansen P
    Int J Cardiol; 2014 Dec; 177(2):e84-6. PubMed ID: 25456696
    [No Abstract]   [Full Text] [Related]  

  • 9. Use of a bioresorbable novolimus eluting vascular scaffold fails a hybrid PCI strategy with drug eluting stent.
    Schneider VS; Skurk C; Riedel M; Abdelwahed YS; Landmesser U; Leistner DM
    Clin Res Cardiol; 2017 Jul; 106(7):557-559. PubMed ID: 28374059
    [No Abstract]   [Full Text] [Related]  

  • 10. Subacute recoil in bioresorbable vascular scaffold in a complex coronary lesion: A lesson from daily clinical practice.
    Centola M; Lucreziotti S; Salerno-Uriarte D; Tresoldi S; Cannone G; Sponzilli C; Carugo S
    Int J Cardiol; 2016 Jan; 203():995-6. PubMed ID: 26625328
    [No Abstract]   [Full Text] [Related]  

  • 11. First US experience following FDA approval of the ABBOTT vascular bioresorbable vascular scaffold for the treatment of coronary artery disease.
    Rizik DG; Shah MG; Burke RF
    Catheter Cardiovasc Interv; 2016 Nov; 88(6):899-901. PubMed ID: 27545489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of acute expansion of bioresorbable vascular scaffolds versus metallic drug-eluting stents in different degrees of calcification: An Optical Coherence Tomography Study.
    Ming Fam J; van Der Sijde JN; Karanasos A; Felix C; Diletti R; van Mieghem N; de Jaegere P; Zijlstra F; Jan van Geuns R; Regar E
    Catheter Cardiovasc Interv; 2017 Apr; 89(5):798-810. PubMed ID: 27717119
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term intravascular follow-up of coronary bifurcation treatment with Absorb bioresorbable vascular scaffold.
    Vanhaverbeke M; McCutcheon K; Dubois C; Bennett J
    Acta Cardiol; 2018 Aug; 73(4):413-414. PubMed ID: 29277145
    [No Abstract]   [Full Text] [Related]  

  • 14. A true bifurcational stenosis treated with a bioresorbable vascular scaffold and a drug-eluting metallic stent: Degradable meets durable.
    Wiebe J; Hamm C; Nef H
    Catheter Cardiovasc Interv; 2015 Jun; 85(7):1184-8. PubMed ID: 25581885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treading the risky ground of coronary bifurcation lesion revascularization, the "biodegradable strategy" may represent the lifeline.
    Piraino D; Buccheri D; Andolina G
    Int J Cardiol; 2016 Oct; 221():577-80. PubMed ID: 27420582
    [No Abstract]   [Full Text] [Related]  

  • 16. Bioresorbable vascular scaffolds in left main coronary artery disease.
    Everaert B; Capranzano P; Tamburino C; Seth A; van Geuns RJ
    EuroIntervention; 2015; 11 Suppl V():V135-8. PubMed ID: 25983148
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hybrid ABSORB bioresorbable vascular scaffold and drug eluting stent or hybrid BVS-DES percutaneous coronary intervention: Method and rationale for hybrid overlapping PCI.
    Yew KL
    Int J Cardiol; 2015; 186():74-6. PubMed ID: 25814348
    [No Abstract]   [Full Text] [Related]  

  • 18. Initial experience of percutaneous coronary intervention in bifurcations with bioresorbable vascular scaffolds using different techniques--insights from optical coherence tomography.
    Attizzani GF; Ohno Y; Capranzano P; La Manna A; Francaviglia B; Grasso C; Sgroi C; Tamburino C; Longo G; Fujino Y; Capodanno D; Tamburino C
    Int J Cardiol; 2013 Dec; 170(2):e33-5. PubMed ID: 24210418
    [No Abstract]   [Full Text] [Related]  

  • 19. Five-year follow-up of the ABSORB bioresorbable everolimus-eluting vascular scaffold system: multimodality imaging assessment.
    García-García HM; Schultz C; Duckers E; Regar E; Ligthart J; Serruys PW; van Geuns RJ
    EuroIntervention; 2013 Feb; 8(10):1126-7. PubMed ID: 23014900
    [No Abstract]   [Full Text] [Related]  

  • 20. Percutaneous coronary intervention: balloons, stents and scaffolds.
    Colleran R; Kastrati A
    Clin Res Cardiol; 2018 Aug; 107(Suppl 2):55-63. PubMed ID: 30039189
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.